American Society of Hematology

Figure 2.

Time to recovery from COVID-19. Defined as time from beginning to end of symptoms, comparing patients with HCL/HCLv with normal B cells 0-25/mm3 (n = 45, □) vs ≥100 cells/mm3 (n = 90, ●).

Time to recovery from COVID-19. Defined as time from beginning to end of symptoms, comparing patients with HCL/HCLv with normal B cells 0-25/mm³ (n = 45, □) vs ≥100 cells/mm³ (n = 90, ●).

This Feature Is Available To Subscribers Only